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Abstract
We evaluated whether the obesity-associated years of life lost (YLL) have decreased over calendar
time. We implemented a meta-analysis including only studies with ≥2 serial BMI assessments at
different calendar years. For each BMI category (normal weight: BMI 18.5 to <25 [reference],
overweight: BMI 25 to <30, grade 1 obesity: BMI 30 to <35, and grade 2–3 obesity: BMI ≥35),
we estimated the YLL change between 1970 and 1990. Due to low sample sizes for blacks, results
are reported on whites. Among men aged≤60 years YLL for grade 1 obesity increased by 0.72
years (p<0.001) and by 1.02 years (p=0.01) for grade 2–3 obesity. For men aged>60, YLL for
grade 1 obesity decreased by 1.02 years (p<0.001), and increased by 0.63 years for grade 2–3
obesity (p=0.63). Among women aged≤60, YLL for grade 1 obesity decreased by 4.21years
(p<0.001) and by 4.97 years (p<0.001) for grade 2–3 obesity. In women aged>60, YLL for grade 1
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obesity decreased by 3.98 years (p<0.001) and by 2.64 years (p=0.001) for grade 2–3 obesity.
Grade 1 obesity’s association with decreased longevity has reduced for older white men. For white
women, there is evidence of a decline in the obesity YLL association across all ages.

Keywords
Body mass index (BMI); years of life lost (YLL); parametric survival; meta-analysis; calendar
time; maturation; recency; length of follow-up; study-level variation; recency

Introduction
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Obese individuals (body mass index [BMI, kg/m2] ≥ 30) are more prone to many adverse
medical conditions, such as cardiovascular disease, stroke, type 2 diabetes mellitus, and
some cancers, and have increased mortality risk from multiple causes (e.g., heart disease and
colon cancer)(1, 2). However, data from the National Health and Nutrition Examination
Survey (NHANES) I (1971–1975), NHANES II (1976–1980), and NHANES III (1988–
1994) have suggested that the BMI-mortality association may have decreased over calendar
time (3). Mehta and Chang, using data from the Framingham Heart Study, the National
Health Interview Survey , and NHANES, also concluded that the excess all-cause mortality
associated with grade 1 obesity has declined over calendar time (4). Gregg et al. (5) found
that, compared with obese persons in the 1960s, those in 1999–2000 had significantly lower
levels of cholesterol, hypertension, and smoking (32% vs. 20%). A recent meta-analysis
based on U.S. as well as non U.S. data present evidence that the excess mortality risk
associated with grade 1 obesity is not statistically significant (6). However, other studies (7–
12) have found that the obesity-mortality association has not decreased in recent years. A
declining association would imply that years of life lost (YLL) associated with obesity have
reduced (13, 14). This declining association, if present, would have substantial public health
implications. A temporal decline in YLL estimates associated with obesity might suggest
that advances in medicine, such as improved screening and interventions for obesityassociated diseases, have been at least somewhat successful in reducing obesity’s
detrimental health effects. Advances in medicine would not be, however, the only possible
explanation.
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Following the Institute of Medicine’s suggestion (15), we conducted a thorough analysis of
data from 17 large, well-characterized U.S. prospective studies to examine whether there is a
decline in the obesity-YLL association

Materials and Methods
Study Selection and Data Extraction
Inclusion criteria were: (a) prospective U.S. based cohort studies with at least 1500
participants; (b) mortality follow-up ≥ 5 years; (c) an accumulation of at least 500 deaths;
(d) BMI (measured or self-reported) available at ≥2 separate time points; and (e) subjects
varied in age at baseline (this last criterion allowed us to construct two different waves
matched for baseline age within each study).
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Studies (16–32) were identified from searches via Medline, PubMed, Scopus, Web of
Science, Journal Citation Reports, and Biological Abstracts (Figure 1). Individual-level data
for these studies were acquired from repositories of the National Heart, Lung and Blood
Institute (NHLBI), Database for Phenotype and Genotype, Inter-University Consortium for
Political and Social Research (ICPSR), and direct contact with investigators. We considered
the 4 study sites of Established Populations for Epidemiologic Studies of the Elderly
(EPESE) as different studies. Data for the Multiple Risk Factor Intervention Trial (MRFIT)
and Hypertension Detection Follow Up (HDFP) consisted of a control group and an
interventional group. Hence, we split these studies into 2 separate cohorts (see Glossary in
the Supporting Information), leading to a total of 19 separate prospective studies for the
meta-analysis (see Table 1).
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Individual-level data for two waves from each study were extracted to account for stable
study-level factors. From each study wave, we extracted information on BMI, sex, baseline
age, race, smoking status, and all-cause mortality. BMI values within each study were
divided into 5 categories: underweight (BMI <18.5), normal weight (BMI 18.5 to <25
[reference category]), overweight (BMI 25 to <30), grade 1 obesity (BMI 30 to < 35), and
grade 2–3 obesity (BMI ≥35), consistent with Flegal et al. (3) and federally defined
categories (33). Race was coded as white, black, and other. Smoking was coded as former
smoker, never smoker, and current smoker.
Rationale for Setting Up Successive Waves Within Each Study
Any changes in the obesity-YLL association might be caused by 1) calendar time (history);
2) the modifying effects of an age-by-BMI interaction (maturation); 3) factors that varied
across the different studies (study level variation); 4) the possibility that one’s BMI in the
recent past has a different effect than one’s BMI in the distant past (recency); and 5) varying
lengths of follow-up (see Glossary and Design Rationale in the Supporting Information)
(34). We implemented a meta-analysis based on a multiple longitudinal design by including
only datasets with serial BMI measurements and overlapping ages at two different calendar
times within a study (Figure 2) (35). This design allows us to disentangle 4 of these 5
possible causes for an observed change in the obesity-YLL association: history, maturation,
recency, and stable study-level factors (see Design Rationale in the Supporting Information)
(36).
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To control for confounding due to length of follow-up, each wave within a study was
restricted to have equal length of follow-up. Using the serial BMI assessments available
within each study, we subdivided each study into two distinct “waves” at different points in
calendar time (Figure 2), with each wave additionally stratified by race and sex (white men,
white women, black men, and black women). To control for confounding due to maturation,
subjects within each study specific race-sex strata were age-matched across the two waves
so as to ensure an identical baseline age distribution (see Methods in the Supporting
Information). Descriptive measures across all study waves following this matching
procedure are provided in Table 2. Because the sample sizes and number of deaths among
black men and women were insufficient after age matching, we report only the results for
white respondents (see Table 2).
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We used a two-stage longitudinal meta-regression to test the hypothesis that calendar time
was associated with changes in the obesity-YLL association (Figure 2 and Design Rationale
in the Supporting Information). Separate analyses were conducted for white men and
women. In stage 1, separately for every wave of a study, we estimated median longevities
(i.e., median age at death) using a parametric Gompertz survival model. Gompertz
distribution is widely used to model mortality data and is suitable for modeling data with
monotone hazard rates that either increase or decrease exponentially with time (37, 38). The
Gompertz distribution is based on the Gompertz law, which dictates that the force of
mortality is exponential. Hence application of the Gompertz law on all-cause mortality
implies that the probability of a person dying increases at a constant exponential rate as age
increases (39, 40). Moreover, parametric survival models are able to provide more direct
answers and consistent YLL estimates regardless of the particular distribution assumed (41).
We computed median longevities for each subject in a study wave using age as time scale
and including baseline age, BMI categories, and smoking status as predictors in the model
(3, 42, 43). Delayed entry was accounted for by left truncating the survival observation
period for each participant at the age they entered the study wave (43–45). Our survival
model, which included time varying coefficients for BMI categories, allowed the hazard
ratio (HR) of each BMI category (relative to normal weight individuals) to vary in three
attained age intervals (≤60, >60 and ≤70, >70) similar to previous NHANES analyses (3,
38). All survival analyses were performed using Stata 12. Because the PSID, EPESE-Duke,
and EPESE-New Haven datasets involved complex sampling designs, sample weights were
utilized for these datasets.
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In stage 2, a meta-regression was used to estimate the change in YLL over calendar time.
The normal weight category was used as a reference when estimating YLL at a given
calendar time. We fitted four separate longitudinal mixed models to estimate the changes in
YLL across calendar time using linear contrasts: white men with baseline ages≤60, white
men baseline with ages>60, white women baseline with ages≤60 and white women with
baseline ages>60. YLL estimates associated with BMI category vary across baseline ages
(12–14). Hence we summarized the changes in YLL for two baseline age strata within men
and women: younger or middle-aged adults (baseline ages≤60) and older adults (baseline
ages>60), similar to Greenberg (12). In each of these meta-regression models the estimated
median longevities derived in stage 1 were regressed on BMI category, baseline age,
calendar time, smoking status, and a BMI category by calendar time interaction. To account
for the heterogeneity or systematic differences in the level of median longevities across
studies at any calendar time, we also included "study" as a random effect (using the MIXED
procedure in SAS 9.2). Moreover, to account for differences in the precision of the estimated
median longevities, the inverse of the sampling variance of the estimated median longevities
was used as weights in the mixed model. Finally, we excluded the underweight category in
stage 2 because of the sparseness of data in this category and since this category is not the
focus of our paper.
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We conducted two sensitivity analyses: (1) to assess the influence of individual studies on
the estimates, we repeatedly fit the stage 2 model after removing each study one at a time,
and (2) we modeled for nonlinear changes by fitting polynomial models that included
quadratic terms for the calendar time by BMI category interactions. For additional
methodological details, see Methods in the online only Supporting Information.

Results
Table 2 shows the descriptive measures of waves across all the studies. The waves within
each study were identical in terms of baseline age distribution, sample-size, and length of
follow-up. The differences in the sample size and number of deaths of white men and
women were due to the inclusion of Nurses’ Health and Nurses’ Health II studies. While the
majority of our white subjects were middle-aged adults, the age range included younger
(age<40) as well as older adults (age>60).
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The results of our primary analysis are presented in Figure 3 and in detail in Table 3. YLL
estimates for a given calendar year (e.g. 1970) were estimated relative to the normal weight
as reference category. Briefly, in comparing YLL estimates between the years 1970 and
1990, we found that among white men ≤ 60, the estimates went down for overweight
subjects, but up for obese subjects. Among white men >60, the YLL estimates decreased
across overweight and grade 1 obesity categories but increased (though not statistically
significantly) for those in the grade 2–3 category. Note that when a YLL estimate is said to
decrease for a BMI category, this means a less deleterious association if being in that BMI
category (relative to the reference category) with longevity. All changes, either positive or
negative, among the white male subjects were fairly modest, with the largest being just over
1 YLL. Among women, the differences were more pronounced. Again comparing YLL
estimates between 1970 and 1990, we found that among white women ≤ 60, YLL decreased
quite markedly: overweight, 2.53 (p<0.001); grade 1 obesity, 4.21(p<0.001); and grade 2–3
obesity, 4.97 (p<0.001). Among white women >60, the data also show substantial YLL
reductions: overweight, 1.99 (p<0.001); grade 1 obesity, 3.98 (p<0.001); and grade 2–3
obesity, 2.64 (p=0.001).

NIH-PA Author Manuscript

Presented in this way, the results are quite striking; however, our sensitivity analyses also
raise some caveats. For example, among white men, our results were sensitive to the
inclusion of the ARIC dataset. Specifically, in white men aged ≤60, the YLL increase of
0.72 years (p<0.001) for grade 1 obesity from 1970 to 1990 changed to a decrease of 2.97
years (p<0.001) when this dataset was excluded (1.43 [95% CI, 1.15 to 1.71] in 1970 and
−1.55 [95% CI, −2.14 to −0.95] in 1990).
Similarly, in white women aged≤60, our results were particularly sensitive to the inclusion
of Nurses’ Health Study (NHS). After excluding the NHS, from 1970 to 1990, the YLL
associated with overweight and grade 2–3 obesity increased 2.74 (p<0.001) and 0.72 years
(p=0.002), respectively. For grade 1 obesity the YLL declined by 0.02 years (p=0.92). In
1970, the YLL for overweight, grade 1 obesity and grade 2–3 obesity were −0.89 (95% CI,
−1.02 to −0.74), 2.42 (95% CI, 2.2 to 2.66) and 2.61 (95% CI, 2.18 to 3.04), respectively. In
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1990, the YLL for overweight, grade 1 obesity and grade 2–3 obesity had changed to 1.86
(95% CI, 1.75 to 1.97), 2.40 (95% CI, 2.25 to 2.56) and 3.33 (95% CI, 3.15 to 3.5),
respectively.
We assessed the robustness of our primary analysis findings by allowing YLL changes to
follow a non-linear pattern (Table 3). We found that our inferences about a decline in the
YLL associations of grade 2–3 obesity and overweight categories in white women aged>60
were sensitive to the assumption of non-linearity. In white women aged>60, the decrease in
YLL associated with grade 2–3 obesity, from 1970 to 1990, was only 0.20 (p=0.80) as
against 2.64 (p=0.001) in the primary analysis. From 1970 to 1990, the decrease in YLL of
1.99 (p<0.001) associated with overweight category in the same group was reversed to an
increase in YLL of 0.56 (p=0.007).

Discussion
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We evaluated whether the detrimental association of obesity to YLL has declined over
calendar time, between 1970 and 1990, after adjusting for confounding due to age-related
effect modification, length of follow-up, recency and stable study level factors (Design
Rationale in the Supporting Information). We found evidence of a consistent decline in the
association of grade 1 obesity to YLL except in men aged≤60. This association remained
deleterious in 1990 with YLL’s of < 1.5 in men and <3.5 in women. The decline in the
association of grade 2–3 obesity to YLL across younger and middle-aged subjects was
inconsistent. There was a statistically significant decline in women but not in men. Despite
this decline, YLL estimates for grade 2–3 obesity in younger and middle-aged subjects
remained elevated even in 1990. In 1990, compared to normal weight, grade 2–3 obese men
could lose up to 4 years while women could lose up to 7 years. Any deleterious association
of overweight to mortality existing in 1970 declined over time, and in some subjects,
overweight was associated with decreased mortality relative to normal weight. In 1990, the
most deleterious association of overweight we found was in women aged≤60 with a YLL of
0.31.
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Sensitivity analyses revealed that our findings for women aged≤60 years were sensitive to
the NHS. NHS, which has an especially large sample size and long follow-up, contributes to
the majority of deaths in the meta-analysis and, thereby, greatly influences the findings for
white women. Excluding NHS from the stage 2 meta-regression resulted in moderate but
statistically significant increases in the YLL estimates of overweight and grade 2–3 obesity
from 1970 to 1990 in contrast to the decrease in YLL observed in the primary analysis
findings. NHS is a cohort of white registered nurses who seem to have lifestyles similar to
the general population (46). Hence, it is plausible that inferences drawn without NHS are
based on substantially lower number of person years and deaths. It is also plausible that
nurses may have witnessed substantial improvements related to calendar time events such as
better access to health care and lifestyle changes. Our grade 1 obesity findings among men
aged≤60 were influenced by ARIC, a middle aged cohort with calendar times 1988 and
1994. The magnitude of increase in the median longevity of grade 1 obese men aged≤60
over calendar time was substantially greater when ARIC was excluded compared to the
primary analysis where ARIC was included. The increase in median longevity of subjects in

Obes Rev. Author manuscript; available in PMC 2015 August 01.

Mehta et al.

Page 7

NIH-PA Author Manuscript

other BMI categories when ARIC was excluded was comparable to the findings in primary
analysis. Hence, there was a statistically significant decline in the YLL associated with
grade 1 obesity over calendar time when ARIC was excluded. Some of our findings were
sensitive to the assumption of linear change in YLL over time. Interestingly, the NHANES
analyses also seem to illustrate a non-linear pattern in the change in HRs especially in the
ages 25–59 years as indicated in figure 1 of Flegal et al. (3).
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Our estimates are generally consistent with those derived by Finkelstein and colleagues, who
estimated YLL associated with overweight and obese categories, for white men and women,
using the National Health Interview Survey respondent data from calendar times 1987 to
2000 (13). Finkelstein and colleagues reported ≤ 1 YLL for grade 1 obese white men while
for white women their estimate was as high as three YLL. They also reported that YLL
estimates for overweight were negative although not statistically significant. Our YLL
estimates for 1990, except for white women aged ≤60 years, also suggest that overweight is
no longer associated with elevated mortality or has a mildly protective association with allcause mortality. Our findings were based on the standard normal weight category (BMI 18.5
to <25) while Finkelstein and colleagues used a narrower reference category (BMI 21 to
<25). This suggests that our findings may be robust to the choice of reference category, a
concern which has been recently cited in reporting results about broad BMI categories (6,
47). We used the broader category to allow comparability to the previous analysis of
NHANES by Flegal et al. (3) which suggested that the deleterious association of obesity had
reduced over calendar time. That said, we recognize and accept the value of the narrower
BMI reference category. A subsequent study by Mehta and Chang(4) found that the grade 1
obesity-mortality association had declined and was not associated with increased mortality
in the later time period. However, unlike Flegal et al. (3), they reported a lack of evidence
for decline in the grade 2–3 obesity-mortality association. Both of these studies provide HR
estimates for calendar times of BMI measured approximately in 1970s and 1990s. Our
findings, which provide YLL estimates for whites only, are at least in partial agreement
though not directly comparable. In contrast to Mehta and Chang’s findings (4), which were
not specific to any race-sex strata, our estimates indicate that a deleterious association of
grade 1 obesity to mortality for younger and middle-aged women remained in 1990. Again
not directly comparable, the pattern of our YLL estimates seem to be in accord with the
results recently reported by Greenberg for adults aged ≤ 55 years (12). Greenberg analyzed
NHANES I, II and III data to estimate the extent to which overweight and obesity hastened
mortality among young and middle-aged adults using a measure similar to YLL (12).
Our study has several strengths. This longitudinal meta-analysis used individual-level data
and allowed for fitting consistent models to each dataset. To our knowledge this is the first
study to estimate changes in obesity-mortality association over calendar time after
accounting for recency, length of follow-up and other stable study level confounders (36).
We used two waves per study which had equal length of follow-up, identical baseline ages
of non-overlapping samples, and homogeneity in race and sex. This is also the first study to
evaluate this question directly in terms of YLL and provide estimates specifically for whites.
While HRs within an attained age category are useful measures, changes in YLL are directly
interpretable and, from a public health perspective, potentially more useful (48).
Interestingly, this was a metric Linus Pauling himself used to quantify the association of
Obes Rev. Author manuscript; available in PMC 2015 August 01.
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obesity with lifespan back in 1958 (49). We also followed upon Sir David Cox’s
recommendation to use a parametric survival model when predicting outcomes specific to a
subject (50). Our survival model in stage 1 allowed the HRs for BMI categories to change
over three attained age intervals. The datasets possessed varying demographic characteristics
and represented different geographical locations in the U.S. and covered a broad range of
calendar time with varying and substantial lengths of follow-up, some over 15 years.
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This study also had limitations, many of which involve logistical and data management
issues. Due to the varying nature of questionnaires across waves within studies and to
maintain analytic consistency, we did not include covariates such as physical activity,
alcohol consumption, nutrition and other predictors that may improve predicting mortality in
presence of BMI (47, 51). We used a two-stage analysis, pooling median longevity estimates
from individual waves, instead of a single stage approach pooling all data and estimating all
model parameters at once. The choice to follow a two-stage approach was driven by data
sharing issues (e.g., not having permission to download mortality follow-up data on our
server), which prevented us from pooling the mortality data across all the studies. However,
there is reason to believe that our two-stage approach should yield similar results to a singlestage approach (52). Finally, the relative dearth of data on minority respondents prohibited
us from deriving reliable estimates for non-whites.
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Our findings concerning overweight and grade 1 obesity are potentially significant to our
understanding of obesity and public health. One of the possibilities suggested, but not
proven, through our findings is that advances in medicine, screening procedures and
interventions may have reduced the excess mortality associated with overweight and grade 1
obesity. For example, Young et al. (53) estimated that half of the reduction in coronary heart
disease (CHD) mortality in the US between 1980 and 2000 can be attributed to reductions in
CHD risk factors. Our study findings also found differences in the YLL estimates and the
reductions in YLL over calendar time between men and women. It has been reported that
women with diabetes are at greater risk of cardiovascular disease (CVD) and CHD than men
compared to their counterparts without diabetes mellitus (54, 55). The differences in YLL of
obesity in men versus women could perhaps be explained by these reported differences in
CVD and CHD risk. The decreases in YLL in women also suggest gender disparities and
gaps in the quality of care may be reducing. Recent data suggests that women tend to use
significantly more health care services and receive better preventive care especially in
therapeutic areas such as CVD (56).
Despite the apparent medical advances in treating weight-related health risk factors, it is
important to note that the disability burden of obesity may still be increasing (57, 58).
Moreover, any potential reduction in the grade 1 obesity-mortality association is likely to
increase healthcare costs (59, 60). The YLL associated with grade 2–3 obesity appear to
remain elevated in younger and middle-aged subjects. The YLL associated with grade 2–3
obesity in men may have actually increased over time. One explanation could be due to the
altered BMI distribution within this broad and open ended category over calendar time.
Given that the U.S. population is getting heavier in general and the grade 2–3 obesity
category includes a lower BMI limit but no upper limit, it is plausible that the mean BMI of
this category in men has increased, perhaps markedly, over calendar time. However, grade
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2–3 obesity is also associated with higher incidences of diabetes and other metabolic
syndromes (61). Recently, Stokes and Mehta found that the deleterious dysglycemiamortality association had not declined between the periods of 1988–2001 and 1999–2006
(62). Finally, the sensitivity of some of our findings suggests caution in interpreting results
of purported changes in the association of BMI categories with functions of mortality over
calendar time. These relationships may vary by study factors that are difficult to estimate
stably such as the shifting of BMI distributions over time (across two waves within a study),
changes in smoking prevalence over time and differences in survey instruments over time.
Future studies may also focus on further identifying specific behavioral or medical practices
or other environmental circumstances that may have contributed to reductions in the
association of grade 1 obesity to mortality.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Selection of Prospective Studies

U.S. based prospective studies with serial BMI measurements were searched and individuallevel data collected.
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Figure 2. Analytic Pipeline

Waves within a study were set up to be identical in terms of length of follow-up, baseline
age distribution, race and sex.
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Figure 3. Stage 2 Meta-Regression Primary Analysis Results
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Changes in the years of life lost (YLL) between 1970 and 1990 estimated from primary
analysis.
YLL were estimated relative to the normal weight. The negative value on the vertical axis
indicates that the YLL estimate declined between 1970 and 1990. For example, the YLL
associated with grade 2–3 obese white women aged > 60 years decreased by approximately
5 years between 1970 and 1990. All the changes were statistically significant at an alpha
level of 0.05 except for the increase in the YLL of grade 2-3 obese men aged >60 years. See
Table 3 for additional details.
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Post Age Matching Summary Measures Across All the US Prospective Cohort Studies
White Men

White Women

Wave 1

Wave 2

Wave 1

Wave 2

Sample Size

12031

12031

62526

62526

Deaths

1955

1646

4679

3640

[46, 53.1, 59.6]

[45.5, 53.1, 59.6]

[40.2, 47.8, 52.4]

[40.1, 47.9, 52.5]

Baseline Ages [25th, 50th, 75th percentile]
Calendar Time [25th, 50th, 75th percentile]

[1973, 1979, 1988]

[1976, 1989, 1992]

Black Men

Black Women

Wave 1

Wave 2

Wave 1

Wave 2

Sample Size

1748

1748

2308

2308

Deaths

265

256

258

258

Calendar Time [25th, 50th, 75th percentile]

[1973, 1982, 1989]

[1974, 1983, 1989]
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White Women Aged≤ 60

White Men Aged>60

Overweight

White Men Aged ≤60

Grade 1 Obesity

Overweight

Grade 2–3 Obesity

Grade 1 Obesity

Overweight

Grade 2–3 Obesity

Grade 1 Obesity

BMI Category

Group

7.31
(7.20, 7.41)
3.10
(3.03, 3.17)

1990

0.31
(0.26, 0.36)

1990
1970

2.84
(2.78, 2.90)

0.49
(0.08, 0.91)

1990
1970

−0.14
(−2.53, 2.25)

0.24
(0.05, 0.43)

1990
1970

1.26
(0.73, 1.80)

−0.20
(−0.31, −0.10)

1990
1970

0.61
(0.33, 0.89)

4.01
(3.51, 4.52)

1990
1970

3.00
(2.47, 3.52)

1.20
(0.89, 1.51)

1990
1970

0.48
(0.26, 0.71)

−0.51
(−0.75, −0.26)

1990
1970

0.01
(−0.14, 0.16)

YLL

−4.21
(p<0.001)

−2.53
(p<0.001)

0.63
(p=0.63)

−1.02
(p<0.001)

−0.82
(p<0.001)

1.02
(p=0.01)

0.72
(p<0.001)

−0.52
(p=0.001)

Difference

Primary Analysis: Only
Linearity in Calendar Time

1970

Calendar
Time

NIH-PA Author Manuscript

Stage 2 Meta-Regression Results

3.31
(3.24, 3.39)

6.08
(5.92, 6.24)

0.27
(0.22, 0.32)

2.84
(2.76, 2.92)

0.62
(0.21, 1.02)

2.40
(−0.32, 5.12)

0.29
(0.10, 0.47)

1.72
(1.15, 2.30)

−0.17
(−0.27, −0.07)

0.29
(0.01, 0.56)

3.87
(3.34, 4.40)

3.44
(2.73, 4.16)

1.30
(0.98, 1.63)

1.11
(0.86, 1.37)

−0.82
(−1.16, −0.48)

0.00
(−0.144, 0.15)

YLL

−2.77
(p<0.001)

−2.57
(p<0.001)

−1.78
(p=0.22)

−1.43
(p<0.001)

−0.46
(p=0.002)

0.42
(p=0.43)

0.19
(p=0.42)

−0.82
(p<0.001)

Difference

Sensitivity Analysis: Model with
Non-Linearity in Calendar Time
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Grade 2–3 Obesity

Grade 1 Obesity

Overweight

3.37
(2.16, 4.57)
0.72
(−0.13, 1.57)

1990

−0.11
(−0.36, 0.13)

1990
1970

3.87
(3.27, 4.47)

−0.41
(−0.56, −0.26)

1990
1970

1.57
(1.23, 1.91)

6.22
(6.13, 6.32)

1990
1970

11.19
(10.99, 11.40)

1970

YLL

−2.64
(p=0.001)

−3.98
(p<0.001)

−1.99
(p<0.001)

−4.97
(p<0.001)

Difference

Primary Analysis: Only
Linearity in Calendar Time

1.29
(0.43, 2.16)

1.49
(0.36, 2.62)

0.42
(0.16, 0.67)

1.99
(1.42, 2.57)

0.12
(−0.03, 0.28)

−0.44
(−0.79, −0.09)

6.97
(6.97, 7.07)

8.01
(7.73, 8.30)

YLL

−0.20
(p=0.80)

−1.57
(p<0.001)

0.56
(p=0.007)

−1.04
(p<0.001)

Difference

Sensitivity Analysis: Model with
Non-Linearity in Calendar Time

YLL estimates based on the stage 2 meta-regression models are reported at calendar times 1970 and 1990. YLL were estimated relative to the normal weight. The change in YLL estimates across these
calendar times and the corresponding p-values indicate whether within a group the deleterious association of an elevated BMI category to increased mortality has decreased over calendar time. A negative
value in the difference estimated indicates that the YLL associated with the respective BMI category has declined between 1970 and 1990.

White Women Aged>60

Grade 2–3 Obesity

Calendar
Time
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